Most Read Articles
26 Dec 2017
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
Elaine Soliven, 20 May 2020
Early treatment with a triple antiviral combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b significantly shortens the duration of virus shedding and reduces symptoms in patients with mild-to-moderate COVID-19 compared with lopinavir-ritonavir only, according to a recent study.
Rachel Soon, 24 Apr 2019

With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.

Elaine Soliven, 24 Feb 2020
Administering intravenous propranolol hydrochloride does not reduce the duration of labour induction for nulliparous women who undergo vaginal delivery, according to a study presented at SMFM 2020.

Vonoprazan more potent than rabeprazole for acid suppression

10 Mar 2020

Vonoprazan at a dosing schedule of 20 mg once daily possesses a more potent and durable acid suppression capabilities relative rabeprazole at 10 or 20 mg twice daily, in addition to a pharmacodynamic profile that makes it useful for inducing early mucosal healing in reflux oesophagitis, according to a study.

Researchers evaluated the acid‐inhibitory effect of vonoprazan 10/20 mg once‐daily (OD; V10/V20) vs rabeprazole 10/20 mg twice‐daily (BID; R20/R40) in three cohorts of 10 healthy Japanese adults. Volunteers in each cohort were randomized to receive V or R for 7 days and then crossed over to the other treatment for another 7 days after a washout period of ≥7 days.

All participants underwent 24‐hours multichannel gastric impedance‐pH monitoring on day 6 of each treatment period. Primary pharmacodynamic endpoints were percent times pH ≥3, ≥4 and ≥5 (pH 3, 4 and 5 holding time ratios [HTRs]) in 24 hours.

V20 exerted a more favourable acid‐inhibitory effect (24‐hour pH 3 HTR) compared with R20 (91.0 percent vs 65.3 percent; p=0.0049) and R40 (98.5 percent vs 85.9 percent; p=0.0073). Results were similar for 24‐hour pH 4 and 5 HTRs.

Compared with R40, V20 also achieved superior nocturnal pH 4 (91.5 percent vs 73.2 percent; p=0.0319) and 5 HTRs (78.8 percent vs 62.2 percent; p=0.0325).

One participant developed diarrhoea while receiving R40, and this was the only adverse event considered treatment‐related.

Despite its potent acid‐inhibitory effect, long‐term use of vonoprazan should be carefully considered as it can lead to sustained hypergastrinemia, which may promote neuroendocrine tumours, according to the researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
26 Dec 2017
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
Elaine Soliven, 20 May 2020
Early treatment with a triple antiviral combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b significantly shortens the duration of virus shedding and reduces symptoms in patients with mild-to-moderate COVID-19 compared with lopinavir-ritonavir only, according to a recent study.
Rachel Soon, 24 Apr 2019

With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.

Elaine Soliven, 24 Feb 2020
Administering intravenous propranolol hydrochloride does not reduce the duration of labour induction for nulliparous women who undergo vaginal delivery, according to a study presented at SMFM 2020.